These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36264145)

  • 1. Serum keratin-18 detects hepatic inflammation and predicts progression in compensated alcohol-associated liver disease.
    Thorhauge KH; Thiele M; Detlefsen S; Rasmussen DN; Johansen S; Madsen BS; Antonsen S; Rasmussen LM; Lindvig KP; Krag A
    Hepatol Commun; 2022 Dec; 6(12):3421-3432. PubMed ID: 36264145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caspase-cleaved keratin-18 fragments increase during alcohol withdrawal and predict liver-related death in patients with alcoholic liver disease.
    Mueller S; Nahon P; Rausch V; Peccerella T; Silva I; Yagmur E; Straub BK; Lackner C; Seitz HK; Rufat P; Sutton A; Bantel H; Longerich T
    Hepatology; 2017 Jul; 66(1):96-107. PubMed ID: 28170108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma Levels of K18 Fragments Do Not Correlate with Alcoholic Liver Fibrosis.
    Schlossberger V; Worni M; Kihm C; Montani M; Datz C; Hampe J; Stickel F
    Gut Liver; 2019 Jan; 13(1):77-82. PubMed ID: 29976035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limited utility of plasma M30 in discriminating non-alcoholic steatohepatitis from steatosis--a comparison with routine biochemical markers.
    Chan WK; Sthaneshwar P; Nik Mustapha NR; Mahadeva S
    PLoS One; 2014; 9(9):e105903. PubMed ID: 25184298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell Death and Prognosis of Mortality in Alcoholic Hepatitis Patients Using Plasma Keratin-18.
    Woolbright BL; Bridges BW; Dunn W; Olson JC; Weinman SA; Jaeschke H
    Gene Expr; 2017 Nov; 17(4):301-312. PubMed ID: 28770701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell death biomarker M65 is a useful indicator of liver inflammation and fibrosis in chronic hepatitis B: A cross-sectional study of diagnostic accuracy.
    Wei X; Wei H; Lin W; Hu Z; Zhang J
    Medicine (Baltimore); 2017 May; 96(20):e6807. PubMed ID: 28514295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of M30/M65 for outcome of hepatitis B virus-related acute-on-chronic liver failure.
    Zheng SJ; Liu S; Liu M; McCrae MA; Li JF; Han YP; Xu CH; Ren F; Chen Y; Duan ZP
    World J Gastroenterol; 2014 Mar; 20(9):2403-11. PubMed ID: 24605039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total Keratin-18 (M65) as a Potential, Early, Non-Invasive Biomarker of Hepatocyte Injury in Alcohol Intoxicated Adolescents-A Preliminary Study.
    Zdanowicz K; Olanski W; Kowalczuk-Kryston M; Bobrus-Chociej A; Werpachowska I; Lebensztejn DM
    Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34207346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expression of serum M30 and M65 in chronic hepatitis B patients with non-alcoholic fatty liver disease.
    Liang J; Han T; Gao YT; Jing L; Ma Z
    Eur Rev Med Pharmacol Sci; 2015 Nov; 19(21):4123-9. PubMed ID: 26592838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caspase-cleaved fragments of cytokeratin-18 as a marker of inflammatory activity in chronic hepatitis B virus infection.
    Bae CB; Kim SS; Ahn SJ; Cho HJ; Kim SR; Park SY; Song GW; Kim DJ; Hwang SG; Yang JM; Kim YB; Park YN; Shin SJ; Cho SW; Cheong JY
    J Clin Virol; 2013 Dec; 58(4):641-6. PubMed ID: 24210327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propofol or sevoflurane anaesthesia does not affect hepatic integrity as assessed by the M30 & M65 cell death markers & liver enzymes.
    Chondrogiannis K; Hadziyannis E; Fassoulaki A
    Indian J Med Res; 2014 Nov; 140(5):630-6. PubMed ID: 25579144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurements of serum procollagen-III peptide and M30 do not improve the diagnostic accuracy of transient elastography for the detection of hepatic fibrosis in patients with nonalcoholic fatty liver disease.
    Ergelen R; Akyuz U; Aydin Y; Eren F; Yilmaz Y
    Eur J Gastroenterol Hepatol; 2015 Jun; 27(6):667-71. PubMed ID: 25923941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of serum M30 and M65 in patients with nasopharyngeal carcinoma.
    Sen F; Yildiz I; Odabas H; Tambas M; Kilic L; Karadeniz A; Altun M; Ekenel M; Serilmez M; Duranyildiz D; Bavbek S; Basaran M
    Tumour Biol; 2015 Feb; 36(2):1039-44. PubMed ID: 25326440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of non-alcoholic fatty liver disease using serum total cell death and apoptosis markers.
    Shen J; Chan HL; Wong GL; Chan AW; Choi PC; Chan HY; Chim AM; Yeung DK; Yu J; Chu WC; Wong VW
    Aliment Pharmacol Ther; 2012 Dec; 36(11-12):1057-66. PubMed ID: 23066946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Keratin 18 Is a Diagnostic and Prognostic Factor for Acute Alcoholic Hepatitis.
    Vatsalya V; Cave MC; Kong M; Gobejishvili L; Falkner KC; Craycroft J; Mitchell M; Szabo G; McCullough A; Dasarathy S; Radaeva S; Barton B; McClain CJ
    Clin Gastroenterol Hepatol; 2020 Aug; 18(9):2046-2054. PubMed ID: 31811953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic and prognostic significance of cell death and macrophage activation markers in patients with hepatocellular carcinoma.
    Waidmann O; Köberle V; Bettinger D; Trojan J; Zeuzem S; Schultheiß M; Kronenberger B; Piiper A
    J Hepatol; 2013 Oct; 59(4):769-79. PubMed ID: 23792028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of an accurate index for predicting outcomes of patients with acute liver failure.
    Rutherford A; King LY; Hynan LS; Vedvyas C; Lin W; Lee WM; Chung RT;
    Gastroenterology; 2012 Nov; 143(5):1237-1243. PubMed ID: 22885329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy of cytokeratin 18 (M30 and M65) in detecting non-alcoholic steatohepatitis and fibrosis: A systematic review and meta-analysis.
    Lee J; Vali Y; Boursier J; Duffin K; Verheij J; Brosnan MJ; Zwinderman K; Anstee QM; Bossuyt PM; Zafarmand MH
    PLoS One; 2020; 15(9):e0238717. PubMed ID: 32915852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of alcoholic liver disease (ALD)/nonalcoholic fatty liver disease (NAFLD) index combined with γ-glutamyl transferase in differentiating ALD and NAFLD.
    Wang J; Li P; Jiang Z; Yang Q; Mi Y; Liu Y; Shi R; Zhou Y; Wang J; Lu W; Li S; Liu D
    Korean J Intern Med; 2016 May; 31(3):479-87. PubMed ID: 27025268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonalcoholic fatty liver disease: biomarkers as diagnostic tools for liver damage assessment in adult patients from Argentina.
    Valva P; Rios D; Casciato P; Gadano A; Galdame O; Mullen E; Bertot G; de Matteo E; Preciado MV
    Eur J Gastroenterol Hepatol; 2018 Jun; 30(6):637-644. PubMed ID: 29384795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.